Morgan Stanley analyst Tejas Savant maintains Natera (NASDAQ:NTRA) with a Overweight and raises the price target from $70 to $72.
Expert Ratings for Elanco Animal Health
Within the last quarter, Elanco Animal Health (NYSE:ELAN) has observed the following analyst ratings: